etomoxir has been researched along with toluene in 1 studies
| Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (toluene) | Trials (toluene) | Recent Studies (post-2010) (toluene) |
|---|---|---|---|---|---|
| 260 | 8 | 93 | 8,863 | 78 | 2,491 |
| Protein | Taxonomy | etomoxir (IC50) | toluene (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Homo sapiens (human) | 2.4526 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, W; Li, J; Liao, B; Yang, J | 1 |
1 other study(ies) available for etomoxir and toluene
| Article | Year |
|---|---|
FFA-ROS-P53-mediated mitochondrial apoptosis contributes to reduction of osteoblastogenesis and bone mass in type 2 diabetes mellitus.
Topics: Adult; Animals; Apoptosis; Benzothiazoles; Bone Density; Cross-Sectional Studies; Diabetes Mellitus, Type 2; DNA, Mitochondrial; Epoxy Compounds; Fatty Acids, Nonesterified; Humans; Lipid Peroxidation; Male; Mice, Inbred C57BL; Middle Aged; Mitochondria; Organophosphorus Compounds; Osteoblasts; Osteogenesis; Reactive Oxygen Species; Toluene; Tumor Suppressor Protein p53; Ubiquinone | 2015 |